Drugs / Magesium sulphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02591004 | Dec 2015 → Oct 2017 | cerebral palsy | Kasr El Aini Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magesium sulphate | “Patients in group A will receive Magesium sulphate 4 gm intravenous (I.V) loading dose over 30 mins” NCT02591004 ↗ |
| Route | Intravenous | “Magesium sulphate 4 gm intravenous (I.V) loading dose” NCT02591004 ↗ |